shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > World News > Article > Pfizer AstraZeneca vaccines protect against Delta variant

Pfizer, AstraZeneca vaccines protect against Delta variant

Updated on: 16 June,2021 07:47 AM IST  |  London
Agencies |

British researchers and a Lancet study find that two doses of these vaccines are ‘highly effective’ in reducing hospitalisation due to the Delta variant

Pfizer, AstraZeneca vaccines protect against Delta variant

Colombian President Ivan Duque receives the first dose of the Pfizer-BioNTech vaccine against COVID-19 in Bogota on June 13. Pics/AFP

New analysis by Britain’s health experts concludes for the first time this week that two doses of Covid-19 vaccines are “highly effective” against hospitalisation from the Delta variant the B1.617.2 extremely transmissible variant first identified in India.


Public Health England (PHE), which has been conducting regular analysis of Covid-19 variants of concern (VOC), said on Monday that the latest analysis shows that the Pfizer/BioNTech vaccine is 96 per cent effective against hospitalisation after two doses and the Oxford/AstraZeneca vaccine is 92 per cent effective against hospitalisation after two doses.


These figures are comparable with vaccine effectiveness against hospitalisation from the Alpha variant, which was first identified in the Kent region of England and was previously the dominant VOC in the UK.


“This evidence of the effectiveness of two doses against variants shows just how crucial it is to get your second jab,” said UK Health Secretary Matt Hancock.

The Delta variant of the novel Coronavirus, first identified in India, doubles the risk of hospitalisation compared to the Alpha variant first found in the UK, but Pfizer and AstraZeneca vaccines provide good protection against the strain, also says a study published in The Lancet journal.

Researchers at Public Health Scotland and the University of Edinburgh, UK, found that the Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India. They also found that two doses of vaccine provide much better protection against the Delta variant compared to a single dose.

California to reopen

California, the first state in America to put in place a coronavirus lockdown, is now turning a page on the pandemic. At the stroke of midnight on Tuesday, California was to lift most of its Covid-19 restrictions and usher in what has been billed as the state’s ‘Grand Reopening.’ Starting Tuesday, there will be no more state rules on social distancing, and no more limits on capacity at restaurants, bars, supermarkets, gyms, stadiums or anywhere else. And no more masks. The US death toll from Covid-19 topped 600,000 on Tuesday, even as the vaccination drive has drastically brought down daily cases and fatalities. 

Israel no longer requires masks indoors

Israel no longer requires masks indoors, lifting one of its last coronavirus restrictions following a highly successful vaccination campaign. The restriction was lifted on Tuesday, though people will still be required to wear masks on airplanes and on their way to quarantine. Unvaccinated individuals must wear masks in nursing homes and other long-term health facilities.

Also Read: SUV bomb scare: NIA nabs 2 men allegedly present during Mansukh Hiran’s killing

1,57,574
No. of new cases reported globally in the past 24 hours

17,58,47,347
Total no. of cases worldwide

38,07,276
Total no. of deaths worldwide

Source: WHO/Johns Hopkins

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK